AI & Machine Learning

Massive Black Market for Unapproved and Potentially Dangerous Obesity Drug Alarms Doctors

26 sec read2 views0 listens

A black market for an unapproved obesity drug called retatrutide has emerged, alarming public health experts. The drug, which is still under development by Eli Lilly and not yet submitted to the FDA, poses significant risks due to potential contamination and lack of regulatory oversight. Tech professionals should be cautious about online health product advertisements and monitor FDA guidelines for safe medication use.

Read the full article at Futurism

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

AI & Machine LearningOct 1832 sec read

The Un-Coded Allergy: Why AI Agents Miss Free-Text Clinical Notes

A patient experienced a severe allergic reaction after an automated prescription system dispensed amoxicillin, despite a documented allergy hidden within unstructured clinical notes. This highlights a critical flaw in AI systems that rely solely on s...

Ali Nemati

AI & Machine LearningOct 1733 sec read

Black Market Retatrutide Linked to Multiple Deaths

Reports indicate that unapproved, black market versions of the experimental weight loss drug retatrutide are linked to at least two deaths, prompting investigation by the Food and Drug Administration. This development highlights the risks associated ...

Ali Nemati

AI & Machine LearningOct 1231 sec read

My cofounder and I were rivals at hackathons. At 21, I've put college on hold to build a startup with him.

A 21-year-old founder has put his college plans on hold after securing $1 million in funding for his startup, Neural Drive, which develops assistive technology using AI. This highlights a growing trend of young individuals prioritizing entrepreneuria...

Ali Nemati